These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2146019)

  • 1. Determination of effective and safe dose for intracoronary administration of nicorandil in dogs.
    Kojima S; Ishikawa S; Ohsawa K; Mori H
    Cardiovasc Res; 1990 Sep; 24(9):727-32. PubMed ID: 2146019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
    Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
    Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine.
    Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):158-66. PubMed ID: 2580137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
    Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
    Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
    Lamping KA; Warltier DC; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective and safe dose of intracoronary nicorandil in man.
    Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
    Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of nicorandil on coronary circulation in ischemic region].
    Chen SL; Zhu MZ; Feng XB; Li LS; Zang YM
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):249-53. PubMed ID: 2150905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):535-42. PubMed ID: 2447402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
    Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicorandil on large epicardial coronary artery in conscious dogs.
    Yamada A; Tomoike H; Hayashi Y; Nishijima H; Nakamura M
    Arzneimittelforschung; 1987 Nov; 37(11):1252-5. PubMed ID: 2964242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium.
    Gross GJ; Pieper GM; Warltier DC
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
    Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischaemic, reperfused porcine hearts.
    Klein HH; Pich S; Lindert-Heimberg S; Schade-Brittinger C; Maisch B; Nebendahl K
    Eur Heart J; 1995 May; 16(5):603-9. PubMed ID: 7588890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels.
    Akai K; Wang Y; Sato K; Sekiguchi N; Sugimura A; Kumagai T; Komaru T; Kanatsuka H; Shirato K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):541-7. PubMed ID: 8569213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term nicorandil application on coronary arteries in conscious dogs.
    Huckstorf C; Bassenge E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S29-33. PubMed ID: 1282173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of nicorandil, calcium chloride and nitroglycerin in treatment of ropivacaine-induced cardiotoxicity.
    Porter JM; Markos F; Snow HM; Shorten GD
    Eur J Anaesthesiol; 2003 Dec; 20(12):939-44. PubMed ID: 14690094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term increases in coronary arterial conductance during five day infusion of low dose nicorandil.
    Bassenge E; Fink B; Sommer O; Huckstorf C
    Cardiovasc Res; 1994 Jun; 28(6):912-6. PubMed ID: 7923298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.